Flow cytometric HLA-B27 typing using CD3 gating and molecules of equivalent soluble fluorochrome (MESF) quantitation

Communications in Clinical Cytometry

Volumn 26, Issue 4, 1996, Pages 286-292

  Chen, Jenn C ^a   Davis, Bruce H ^a   Bigelow, Nancy C ^a   Ceckowski, Carole ^a   Robinson, JoAnne ^a   Sounart Miscovich, Cynthia ^a   Steel, Kathrine A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

ankylosing spondylitis; arthritis; genetic diseases; HLA typing; quantitative fluorescence

Indexed keywords

CD3 ANTIGEN; HLA B27 ANTIGEN;

ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REITER SYNDROME;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CROSS REACTIONS; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HLA-B27 ANTIGEN; HUMANS; LINEAR MODELS; QUALITY CONTROL;

EID: 0030461761     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19961215)26:4<286::AID-CYTO8>3.0.CO;2-A     Document Type: Article

References (26)

1. Brewerton DA, Hart FD, Caffrey M, Nicholls A, James DCO, Sturrock RD: Ankylosing spondylitis and HLA-B27. Lancet 1:904-907, 1973.
2. Tiwari JI, Terasaki PI HLA and Disease Association. Springer, New York, 1985.
3. Lopez de Castro JA: HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today 10:239-246, 1989.
4. Hill AVS, Allsopp CEM, Kwiatknoske D, Anstey NM, Greenwood BM, McMichael AJ: HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 337:640-642, 1991.
5. Albrecht J, Muller HAG: HLA-B27 typing by use of flow cytofluorometry. Clin Chem 33:1619-1623, 1987.
6. Eastman PJ, Baier KA, Bryan CF: HLA-B27 Typing, a comparative evaluation between the standard NIH method and flow cytometry. Ann NY Acad Sci 677:402-403, 1993.
7. Ward AM, Nikaein A: Comparison of monoclonal antibodies for flow cytometric analysis of HLA-B27 antigen. Cytometry 22:65-69, 1995.
8. Pei R, Arjomand-Shamsai M, Deng CT, Cesbron A, Bignon JD, Lee JH: A monospecific HLA-B27 fluorescein isothiocyanate-conjugated monoclonal antibody for rapid, simple, and accurate HLA-B27 typing. Tissue Antigens 41:200-203, 1993.
9. Lingenfelter B, Fuller TC, Hartung L, Hunter J, Wittwer C: HLA-B27 screening by flow cytometry. Cytometry 22:146-149, 1995.
10. Reynolds WM, Evans PR, Lane AC, Martin Howell W, Wilson PJ, Wong R, Smith JL: Automated HLA-B27 testing using the FACSPrep/ FACScan system. Cytometry 18:109-115, 1994.
11. Shapiro HM: Practical flow cytometry, Ed. 3. Alan R. Liss, Inc., New York, 1994.
12. Schwartz A, Fernandez-Repollet E: Technical aspects of fluorescence quantitative measurements by flow cytometry. Clin Immunol Newsletter 15:73-77, 1995.
13. Oonishi T, Uyesaka N: A new standard fluorescence microsphere for quantitative flow cytometry. J Immunol Methods 84:143-154, 1985.
14. Vindelov LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 5:323-327, 1983.
15. Creamer P, Edmonds J, Sullivan J, Matthews S: Measurement of HLA class I expression in ankylosing spondylitis. Ann Rheum Dis 51:1138-1142, 1992.
16. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki V: Microdroplet testing for HLA-A, -B, -C, and -D antigens. Am J Clin Pathol 69:103-120, 1978.
17. Schwartz A, Fernandez-Repollete E: Development of clinical standards for flow cytometry. Ann NY Acad Sci 677:28-39, 1993.
18. Janssen WCM, Rouwen JACN, Hoffmann JJML: Improved flow cytometric method for HLA-B27 typing. Ann Clin Biochem 29:663-667, 1992.
19. γR in Inflammation: Basic Principles and Clinical Correlates, Ed. 2. Gallin JI, Goldstein IM, Snyderman R. (eds). Raven Press, Ltd., New York, 1992, p. 497.
20. Lindaho P, Gresser I, Leary P, Tovey M: Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci USA 73:1284-1287, 1976.
21. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS: Widespread and selective induction of major histocompacibility complex-determined antigens in vivo by gamma Interferon J Exp Med 162:1645-1664, 1985.
22. Taniguchi T: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251-255, 1995.
23. Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE: Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 150:4168-4178, 1993.
24. Blasczyk R, Weber M, van Lessen A, Schwella N, Huhn D, Salama A: Discrimination of HLA-B27 alleles by group-specific amplification followed by solid-phase sequencing. Hum Immunol 45:117-123, 1996.
25. Dominguez O, Coto E, Martinez-Naves E, Choo SY, Lopez-Larrea C: Molecular typing of HLA-B27 alleles. Immunogenetics 36:277-282, 1992.
26. Lowder JN: Diagnostic use of HLA-B27 in the management of seronegative spondyloarhtropathies: Methods for detection. Clin Immunol Newsletter 16:1-10, 1966.